13
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Sensitization with atypical mycobacteria is a potent risk factor for cross-reaction with the delayed type hypersensitivity assay in mice

, , , , &
Pages 91-97 | Published online: 16 Jul 2010

References

  • Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA. 2005;293:2767–2775.
  • Vasconcelos-Junior AC, Araújo-Filho JA, Silva EB, Sousa EM, Kipnis A, Junqueira-Kipnis AP. Limitations of the BCG vaccine and new prophylaxis strategies against human tuberculosis. Einstein. 2009;7:383–389.
  • Nelson K. Tuberculin testing to detect latent tuberculosis in developing countries. Epidemiology. 2007;18:348–349.
  • García-Sancho FMC, García-García L, Jiménez-Corona ME, et al. Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG- vaccinated children? Int J Epidemiol. 2006;35:1447–1454.
  • Hizel K, Maral I, Karakus R, Aktas F. The influence of BCG immunization on tuberculin reactivity and booster effect in adults in a country with a high prevalence of tuberculosis. Clin Microbiol Infect. 2004;10:980–983.
  • Teixeira EG, Kritski A, Ruffino-Netto A, et al. Two-step tuberculin skin test and booster phenomenon prevalence among Brazilian medical students. Int JTuberc Lung Dis. 2008;12:1407–1413.
  • Reid JK, Ward H, Marciniuk D, Hudson S, Smith P, Hoeppner V The effect of neonatal bacille Calmette-Guérin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Chest. 2007;131:1806–1810.
  • Menzies D. What does tuberculin reactivity after bacille Calmette- Guérin vaccination tell us? Clin Infect Dis. 2000;31(3):71–73.
  • Verbon A, Cobelens FG. Indications for, and the significance of, the tuberculin test in the Netherlands. Ned Tijdschr Geneeskd. 2003;147: 539–543.
  • Wu X, Zhang L, Zhang J, Zangh C, Zhu L, Shi Y. Recombinant early secreted antigen target 6 protein as a skin test antigen for the specific detection of Mycobacterium tuberculosis infection. Clin Exp Immunol. 2008;152:81–87.
  • Bozaykut A, Ipek IO, Ozkars MY, Seren LP, Atay E. Effect of BCG vaccine on tuberculin skin tests in 1–6-year-old children. Acta Paediatr. 2002;91:235–238.
  • Miranda A, Amadeu TP, Schueler G, et al. Increased Langerhans cell accumulation after mycobacterial stimuli. Histopathology. 2007; 51:649–656.
  • Henderson RA, Watkins SC, Flynn JL. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J Immunol. 1997;159:635–643.
  • Inaba K, Inaba M, Naito M, Steinman RM. Dendritic-cell progenitors phagocytose particulates, including bacillus Calmette – Guérin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med. 1993;178:479–488.
  • Callard RE, Harper JI. The skin barrier, atopic dermatitis and allergy: a role of langerhans cells? Trends Immunol. 2007;28:294–298.
  • Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis. 2009;69:359–369.
  • Palmer CE, Long MW. 1966. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966;94:553–568.
  • Shield MJ, Stanford JL, Rook GAW The reason for the reduction of the protective efficacy of BCG in Burma. Int J Leprosy. 1979;47:319–320.
  • Al-Orainey IO. Diagnosis of latent tuberculosis: can we do better? Ann Thorac Med. 2009;4:5–9.
  • Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int JTuberc Lung Dis. 2006;13:1192–1204.
  • de Kantor IN, Ritacco V Is the tuberculin skin test still suitable to diagnose tuberculosis infection? Medicina. 2009;69:359–369.